Gilead Sciences (GILD) Revenue Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
55.54% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
9.91% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
12.43% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
4.87% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
5.76% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
4.39% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
10.70% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
2.57% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
4.39% |
| Dec 31, 2025 |
4.70% |
| Sep 30, 2025 |
2.97% |
| Jun 30, 2025 |
1.84% |
| Mar 31, 2025 |
-0.28% |
| Dec 31, 2024 |
6.40% |
| Sep 30, 2024 |
7.01% |
| Jun 30, 2024 |
5.38% |
| Mar 31, 2024 |
5.26% |
| Dec 31, 2023 |
-3.72% |
| Sep 30, 2023 |
0.13% |
| Jun 30, 2023 |
5.42% |
| Mar 31, 2023 |
-3.61% |
| Dec 31, 2022 |
2.00% |
| Sep 30, 2022 |
-5.11% |
| Jun 30, 2022 |
0.69% |
| Mar 31, 2022 |
2.60% |
| Dec 31, 2021 |
-2.39% |
| Sep 30, 2021 |
12.83% |
| Jun 30, 2021 |
20.88% |
| Mar 31, 2021 |
15.77% |
| Dec 31, 2020 |
26.23% |
| Sep 30, 2020 |
17.36% |
| Jun 30, 2020 |
-9.53% |
| Mar 31, 2020 |
5.06% |
| Dec 31, 2019 |
1.45% |
| Sep 30, 2019 |
0.14% |
| Jun 30, 2019 |
0.66% |
| Mar 31, 2019 |
3.79% |
| Dec 31, 2018 |
-2.59% |
| Sep 30, 2018 |
-14.07% |
| Jun 30, 2018 |
-20.91% |
| Mar 31, 2018 |
-21.78% |
| Dec 31, 2017 |
-18.73% |
| Sep 30, 2017 |
-13.17% |
| Jun 30, 2017 |
-8.17% |
| Mar 31, 2017 |
-16.54% |
| Dec 31, 2016 |
-13.94% |
| Sep 30, 2016 |
-9.58% |
| Jun 30, 2016 |
-5.68% |
| Mar 31, 2016 |
2.63% |
| Dec 31, 2015 |
16.30% |
| Sep 30, 2015 |
37.29% |
| Jun 30, 2015 |
26.15% |
| Mar 31, 2015 |
51.91% |
| Dec 31, 2014 |
134.42% |
| Sep 30, 2014 |
117.10% |
| Jun 30, 2014 |
136.18% |
| Mar 31, 2014 |
97.43% |
| Dec 31, 2013 |
20.54% |
| Sep 30, 2013 |
14.69% |
| Jun 30, 2013 |
15.04% |
| Mar 31, 2013 |
10.93% |
| Dec 31, 2012 |
17.63% |
| Sep 30, 2012 |
14.37% |
| Jun 30, 2012 |
12.54% |
| Mar 31, 2012 |
18.50% |
| Dec 31, 2011 |
10.09% |
| Sep 30, 2011 |
9.50% |
| Jun 30, 2011 |
10.90% |
| Mar 31, 2011 |
-7.66% |
| Dec 31, 2010 |
-1.66% |
| Sep 30, 2010 |
7.56% |
| Jun 30, 2010 |
17.00% |
| Mar 31, 2010 |
36.29% |
